| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3732729
Max Phase: Preclinical
Molecular Formula: C19H25BrN4O2S
Molecular Weight: 453.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NC1CCCNC1)[C@H]1[C@H](C(=O)Nc2ncc(Br)s2)[C@@H]2CC[C@H]1C21CC1
Standard InChI: InChI=1S/C19H25BrN4O2S/c20-13-9-22-18(27-13)24-17(26)15-12-4-3-11(19(12)5-6-19)14(15)16(25)23-10-2-1-7-21-8-10/h9-12,14-15,21H,1-8H2,(H,23,25)(H,22,24,26)/t10?,11-,12+,14-,15-/m1/s1
Standard InChI Key: BECUZOPGDIDRHF-IHZUMSIISA-N
Associated Targets(Human)
FML2_HUMAN 519 Activities
Lipoxin A4 receptor 3472 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 453.41 | Molecular Weight (Monoisotopic): 452.0882 | AlogP: 2.76 | #Rotatable Bonds: 4 |
| Polar Surface Area: 83.12 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 7.87 | CX Basic pKa: 9.53 | CX LogP: 0.85 | CX LogD: 0.31 |
| Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.66 | Np Likeness Score: -0.62 |
References
| 1. (2012) Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists, |
Source
Source(1):